Sana Biotechnology Inc.
(SANA)
undefined
undefined%
At close: undefined
1.93
2.39%
After-hours Dec 13, 2024, 07:59 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Revenue | - | - | - | - | - | - |
Cost of Revenue | 30.86M | 27.73M | 17.91M | 10.17M | 3.92M | 1K |
Gross Profit | -30.86M | -27.73M | -17.91M | -10.17M | -3.92M | -1K |
Operating Income | -326.90M | -272.56M | -356.91M | -286.15M | -141.15M | -8.22M |
Interest Income | 9.94M | 3.76M | 676.00K | 747.00K | 2.86M | - |
Pretax Income | -283.25M | -269.48M | -355.93M | -285.31M | -138.32M | -13.25M |
Net Income | -283.25M | -266.39M | -344.18M | -278.64M | -130.78M | -13.25M |
Selling & General & Admin | 73.30M | 71.56M | 50.41M | 28.27M | 21.78M | 4.21M |
Research & Development | 221.64M | 201.00M | 306.50M | 257.88M | 119.38M | 4.01M |
Other Expenses | - | -674.00K | 305.00K | 97.00K | -29.00K | - |
Operating Expenses | 294.94M | 272.56M | 356.91M | 286.15M | 141.15M | 8.22M |
Interest Expense | - | - | - | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - | -4.21M |
Cost & Expenses | 325.81M | 272.56M | 356.91M | 286.15M | 141.15M | 8.22M |
Income Tax | - | -3.09M | -11.75M | -6.67M | -7.55M | - |
Shares Outstanding (Basic) | 194.54M | 188.34M | 166.43M | 187.51M | 187.34M | 187.34M |
Shares Outstanding (Diluted) | 194.54M | 188.34M | 166.43M | 187.51M | 187.34M | 187.34M |
EPS (Basic) | -1.46 | -1.41 | -2.07 | -1.49 | -0.7 | -0.07 |
EPS (Diluted) | -1.46 | -1.41 | -2.07 | -1.49 | -0.7 | -0.07 |
EBITDA | -252.39M | -256.94M | -356.91M | -287.03M | -138.90M | -13.25M |
Depreciation & Amortization | 30.86M | 27.73M | 17.91M | 10.17M | 3.92M | 1K |